News and Insights

Newsletter

Biospring Backs CenExel; PathAI Expands Offering Post FDA Approval

Biospring is pleased to announce our recent investment in CenExel, a clinical trial site network across the U.S. offering...

Learn More

April 14, 2025

Biospring Interview with Britt Harris (UTIMCO)

Interview

April 11, 2024

Primer: Radiopharma Overview

January 05, 2024

Panel Discussion: Navigating Biopharma Deals

November 09, 2023

Market Trends and Outlook with Michael Rosen, CIO Angeles Investments

November 09, 2022

Biospring Partners Welcomes Industry Executives To Its Advisory Board

August 01, 2022

Biomanufacturing: A Growing Field

May 30, 2022

Interview with Zach Weinberg

April 26, 2022

Driving Drug Development with Data Science

April 26, 2022

Kiniciti, Ncardia, and the Future of Cell & Gene Therapy

April 26, 2022

Our investment in Kiniciti

April 26, 2022

Cell and Gene Therapy 101: A Primer on Advanced Therapies

April 26, 2022

How ixlayer is driving telehealth transformation

April 26, 2022

Vaccines, Return to Work & the Economy

April 26, 2022

The Opportunities for AI in Drug Discovery

April 25, 2022

Biospring Partners Expands Team and Announces its Advisory Board

Prev 1 2 Next

Newsletter

Privacy Policy | ©2025 All Rights Reserved Biospring